- Home
- ESPR vs LPA Comparison
ESPR vs LPA Comparison
Compare ESPR & LPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- LPA
- Stock Information
- Founded
- ESPR 2008
- LPA 2013
- Country
- ESPR United States
- LPA United States
- Employees
- ESPR N/A
- LPA N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- LPA
- Sector
- ESPR Health Care
- LPA
- Exchange
- ESPR Nasdaq
- LPA Nasdaq
- Market Cap
- ESPR 305.0M
- LPA 310.7M
- IPO Year
- ESPR 2013
- LPA N/A
- Fundamental
- Price
- ESPR $1.50
- LPA $9.30
- Analyst Decision
- ESPR Buy
- LPA
- Analyst Count
- ESPR 7
- LPA 0
- Target Price
- ESPR $6.36
- LPA N/A
- AVG Volume (30 Days)
- ESPR 3.5M
- LPA 6.6K
- Earning Date
- ESPR 03-04-2025
- LPA 03-25-2025
- Dividend Yield
- ESPR N/A
- LPA N/A
- EPS Growth
- ESPR N/A
- LPA N/A
- EPS
- ESPR N/A
- LPA N/A
- Revenue
- ESPR $332,314,000.00
- LPA $44,311,428.00
- Revenue This Year
- ESPR $5.51
- LPA N/A
- Revenue Next Year
- ESPR $1.42
- LPA N/A
- P/E Ratio
- ESPR N/A
- LPA N/A
- Revenue Growth
- ESPR 185.66
- LPA 22.46
- 52 Week Low
- ESPR $1.47
- LPA $6.00
- 52 Week High
- ESPR $3.94
- LPA $525.00
- Technical
- Relative Strength Index (RSI)
- ESPR 34.95
- LPA N/A
- Support Level
- ESPR $1.57
- LPA N/A
- Resistance Level
- ESPR $1.86
- LPA N/A
- Average True Range (ATR)
- ESPR 0.13
- LPA 0.00
- MACD
- ESPR -0.01
- LPA 0.00
- Stochastic Oscillator
- ESPR 7.69
- LPA 0.00
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About LPA Logistic Properties of the Americas
Logistic Properties of the Americas is a fully-integrated, internally managed real estate company that develops, owns and manages a diversified portfolio of warehouse logistics assets in Central America and the South America. It focuses on modern Class A logistics real estate in high growth and high barrier-to-entry markets that are undersupplied and have low penetration rates.